Fogicap powder 20 Medboide Treatment of stomach - duodenal ulcer, gastric esophagus (30 packs)

Dosage form 30 package box
Specifications Omeprazole, sodium bicarbonate

Ingredient

Composition information	Content
Omeprazole	20mg
Sodium bicarbonate	1680mg

Uses

indications

Fogicap 20 drugs indicated treatment in the following cases:

duodenum ulcer: Fogicap 20 is indicated for short -term treatment in duodenal ulcer. Most patients heal after four weeks. Some patients need to be added 4 weeks.

Stomach ulcer: Fogicap 20 is indicated for short-term treatment (4-8 weeks) in stomach ulcer.

Treatment in gastric esophagus recovery (GERD):

Symptomic gastric esophagus disease: Fogicap 20 is indicated for heart heart treatment and other symptoms related to gastric esophagus recovery. indicated in maintenance treatment in corrosive esophagitis. Controlled studies with no more than 12 months.

pharmacokinetics

No data.

Before taking Fogicap powder 20 Medboide Treatment of stomach - duodenal ulcer, gastric esophagus (30 packs)

How to use

Put the powder in a small cup containing 1-2 tablespoons of filtered water (about 30 ml). Do not use any other liquid or food. Stir thoroughly and use immediately. Rinse the cup with water and drink.

If using fogicap 20 through the nasal - stomach catheter or mouth - stomach catheter, the mixture should be mixed with about 20 ml of filtered water. Do not use any other liquid or food. Stir thoroughly and use immediately. A reasonable syringe should be used to pump the mixture into the catheter. Should be coated in the tube with about 20 ml of water.

Fogicap 20 should be taken at an empty stomach, at least 1 hour before meals.

For patients who are still using nasal - stomach or mouth - stomach catheter, food should be used about 3 hours ago and 1 hour after using Fogicap 20.

Dosage

Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

Overdose:

Overdose with Omeprazol in humans has been reported. The dose is up to 2,400 mg (120 times the normal dose). Symptomatic symptoms include disorders, chicken sleep, blurred vision, fast heartbeat, nausea, vomiting, sweating, redness, headache, dry mouth and other side effects. These symptoms are temporary and have no serious clinical consequences reported when using alone Omeprazol. In addition, overdose of sodium bicarbonate can cause hypocalcaemia, hypokalemia, hyperiemia and convulsions.

How to handle:

There is no specific antidote when overdose of omeprazol. In case of overdose, symptomatic treatment and support.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

The following unwanted effects are described below and other parts of the user manual:

Body: Hypersensitivity reaction, including anaphylaxis, angioedema, bronchospasm, interstitial nephritis, urticaria, fever, pain, fatigue, discomfort.

Cardiovascular: chest pain or angina, tachycardia, bradycardia, chest drum, increased blood pressure and peripheral edema.

Digestive: Pancreatitis (deadly in some cases), anorexia, colon stimulation, flatulence, discoloration of stool, esophagus Candida infection, tongue mucosa, dry mouth, stomach and abdominal swelling. Stomach gland polyps have been recorded but rarely during treatment with omeprazole. The polyps are benign and seem to be reversed when stopped. Stomach carcinoid syndrome has been reported in patients with Zollinger Ellison syndrome when long -term treatment with omeprazole. This finding is thought to be a hidden manifestation related to tumors.

Liver: light and rare, marking the increase in liver function tests [ALT (SGPT), AST (SGOT), γ-Glutamyl Transpeptidase, alkaline phosphatase, and bilirubin (jaundice)]. In some rare cases, excessive liver disease has occurred, including hepatitis, bile stasis or mixed hepatitis, liver necrosis (some fatal), liver failure (some deaths) and liver brain disease.

Infection and parasitic infection: diarrhea associated with Clostridium difficile

Metabolism and nutritional disorders: hypoglycemia, hypoglycemia, hypoglycemia and weight gain.

musculoskeletal: muscle pain, muscle weakness, joint pain, fracture and leg pain.

Nervous/mental system: Mental disorders include depression, agitation, aggression, hallucinations, confusion, insomnia, suspense, tremor, indifference, drowsiness, anxiety, abnormal dreams; dizzy; Hemifacial.

Respiratory: Nose bleeding, sore throat.

Skin: serious general skin reactions include toxic epidermal necrosis (ten; some death), Stevens-Johnson syndrome and diverse erythema (some serious cases); BODY BLANG AND / or Petechiae (some reacts back); Dermatitis, urticaria, angioedema, itching, light sensitivity, hair loss, dry skin and increased sweating.

Special senses: tinnitus, taste.

Eyes: blurred vision, eye irritation, dry eye syndrome, eye atrophy, optic neuropathy due to ischemia, optic neuritis and double view.

Genital urinary: interstitial nephritis (some positive reactions), urinary tract infections, microscopic ureter, urinary frequency, increased serum creatinine, proteinuria, blood urine, glycos urinary, testicular pain and gynecological pain.

Hematology: The rare cases of panctopenia, grain leukemia (some fatal), thrombocytopenia, leukopenia, anemia, leukemia and hemolytic anemia have been reported.

The incidence of harmful reactions in patients greater than 65 years old is similar to patients from 65 years of age.

Additional harmful reactions can be caused by sodium bicarbonate including metabolic alkaline infection, seizures and spasms

Notice immediately to the doctor or pharmacist the harmful reactions encountered when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Fogicap medicine 20 Contraindicated in the following cases:

Fogicap 20 Contraindicated in patients with hypersensitivity to any component of the drug and patients under 18 years old.

Be cautious when using

The presence of stomach malignancy: In adults, the symptomatic response to fogicap 20 does not prevent the presence of malignant tumor in the stomach. Atrophic gastritis is sometimes recorded in gastric biopsy samples from long -term patients with Omeprazol.

Acute interstitial nephritis: Acute interstitial nephritis has been observed in patients using ppi including fogicap 20. Interstitial nephritis can occur at any time during the PPI treatment process and often due to an idiopathic hypersensitivity reaction. Stop using fogicap 20 if acute interstitial nephritis develops.

The effect of the drug on driving and operating machinery

No data.

Use drugs for women during pregnancy and lactation

Follow the prescription from the doctor. The drug should only be used when the benefits are out of risks.

Drug interaction

drug interactions can affect the activity of the drug or cause side effects.

Patients should notify the doctor or pharmacist a list of the drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.

Please see more information about drugs in the instructions for the use of drugs attached.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.